{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T06:10:36Z","timestamp":1773900636257,"version":"3.50.1"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","award":["777365"],"award-info":[{"award-number":["777365"]}],"id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["681002"],"award-info":[{"award-number":["681002"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["964537"],"award-info":[{"award-number":["964537"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010648","name":"Universitaire Ziekenhuizen Leuven, KU Leuven","doi-asserted-by":"publisher","award":["FWO-SBO-QPG-359638-iPSC-LIMIC"],"award-info":[{"award-number":["FWO-SBO-QPG-359638-iPSC-LIMIC"]}],"id":[{"id":"10.13039\/501100010648","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s00204-025-04226-6","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T06:49:07Z","timestamp":1762325347000},"page":"585-601","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A broad kinase inhibitor library live cell imaging screen using liver, kidney and cardiac hiPSC-ICAM1-eGFP reporter lineages identifies liabilities for TNF\u03b1 pathway modulation"],"prefix":"10.1007","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0910-8865","authenticated-orcid":false,"given":"Matthijs","family":"Vlasveld","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7887-2050","authenticated-orcid":false,"given":"Linda","family":"van den Berk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet","family":"Pi\u00f1ero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8393-9047","authenticated-orcid":false,"given":"Palle S.","family":"Helmke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerhard F.","family":"Ecker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rob","family":"van Rossom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1085-9372","authenticated-orcid":false,"given":"Bela Z.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Verfaillie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos","family":"Tassis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Callegaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9252-5896","authenticated-orcid":false,"given":"Peter","family":"Bouwman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bob","family":"van de Water","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,5]]},"reference":[{"issue":"11S","key":"4226_CR1","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1681\/asn.20233411s1482b","volume":"34","author":"A Amer","year":"2023","unstructured":"Amer A, Nabil C-C, Kitchlu A (2023) A case of acute interstitial nephritis associated with belvarafenib, a novel pan-RAF kinase inhibitor for metastatic NRAS mutant melanoma. J Am Soc Nephrol 34(11S):482\u2013482. https:\/\/doi.org\/10.1681\/asn.20233411s1482b","journal-title":"J Am Soc Nephrol"},{"key":"4226_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcb.2020.12.003","author":"RJ Antonia","year":"2021","unstructured":"Antonia RJ, Hagan RS, Baldwin AS (2021) Expanding the view of IKK: new substrates and new biology. Trends Cell Biol. https:\/\/doi.org\/10.1016\/j.tcb.2020.12.003","journal-title":"Trends Cell Biol"},{"issue":"1","key":"4226_CR3","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1124\/mol.112.084053","volume":"84","author":"Benedetti G, Fokkelman M, Yan K, Fredriksson L, Herpers B, Meerman J, van de, and de Graauw M. Water B","year":"2013","unstructured":"Benedetti G, Fokkelman M, Yan K, Fredriksson L, Herpers B, Meerman J, van de, and de Graauw M. Water B (2013) The nuclear factor \u039aB family member RelB facilitates apoptosis of renal epithelial cells caused by cisplatin\/tumor necrosis factor \u03b1 synergy by suppressing an epithelial to mesenchymal transition-like phenotypic switch. Mol Pharmacol 84(1):128\u2013138","journal-title":"Mol Pharmacol"},{"issue":"2","key":"4226_CR4","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.bcp.2012.10.012","volume":"85","author":"G Benedetti","year":"2013","unstructured":"Benedetti G, Fredriksson L, Herpers B, Meerman J, Van De Water B, De Graauw M (2013a) TNF-\u03b1-mediated NF-\u039aB survival signaling impairment by cisplatin enhances JNK activation allowing synergistic apoptosis of renal proximal tubular cells. Biochem Pharmacol 85(2):274\u2013286. https:\/\/doi.org\/10.1016\/j.bcp.2012.10.012","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"4226_CR5","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/7651_2014_178","volume":"1353","author":"CW Berg","year":"2014","unstructured":"Berg CW, Den V, Elliott DA, Braam SR, Mummery CL, Davis RP (2014) Differentiation of human pluripotent stem cells to cardiomyocytes under defined conditions. Methods Mol Biol 1353(1):163\u2013180. https:\/\/doi.org\/10.1007\/7651_2014_178","journal-title":"Methods Mol Biol"},{"issue":"8","key":"4226_CR6","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1002\/emmm.201000085","volume":"2","author":"F B\u00f6hm","year":"2010","unstructured":"B\u00f6hm F, K\u00f6hler UA, Speicher T, Werner S (2010) Regulation of liver regeneration by growth factors and cytokines. EMBO Mol Med 2(8):294\u2013305. https:\/\/doi.org\/10.1002\/emmm.201000085","journal-title":"EMBO Mol Med"},{"issue":"1","key":"4226_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-020-15058-6","volume":"11","author":"R Boon","year":"2020","unstructured":"Boon R, Kumar M, Tricot T, Elia I, Ordovas L, Jacobs F, One J et al (2020) Amino acid levels determine metabolism and CYP450 function of hepatocytes and hepatoma cell lines. Nat Commun 11(1):1\u201316. https:\/\/doi.org\/10.1038\/s41467-020-15058-6","journal-title":"Nat Commun"},{"key":"4226_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/nri3834","author":"D Brenner","year":"2015","unstructured":"Brenner D, Blaser H, Mak TW, Nature Publishing Group (2015) Regulation of tumour necrosis factor signalling: live or let die. Nat Rev Immunol. https:\/\/doi.org\/10.1038\/nri3834","journal-title":"Nat Rev Immunol"},{"issue":"April","key":"4226_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphar.2021.598549","volume":"12","author":"C Campana","year":"2021","unstructured":"Campana C, Dariolli R, Boutjdir M, Sobie EA (2021) Inflammation as a risk factor in cardiotoxicity: an important consideration for screening during drug development. Front Pharmacol 12(April):1\u20138. https:\/\/doi.org\/10.3389\/fphar.2021.598549","journal-title":"Front Pharmacol"},{"key":"4226_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-020-00322-w","author":"B Canovas","year":"2021","unstructured":"Canovas B, Nebreda AR (2021) Diversity and versatility of P38 kinase signalling in health and disease. Nat Rev Mol Cell Biol. https:\/\/doi.org\/10.1038\/s41580-020-00322-w","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"4226_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-89550-4","volume":"11","author":"V Chandrasekaran","year":"2021","unstructured":"Chandrasekaran V, Carta G, da Costa D, Pereira RG, Murphy C, Feifel E, Kern G et al (2021) Generation and characterization of IPSC-derived renal proximal tubule-like cells with extended stability. Sci Rep 11(1):1\u201317. https:\/\/doi.org\/10.1038\/s41598-021-89550-4","journal-title":"Sci Rep"},{"issue":"5","key":"4226_CR12","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1681\/ASN.2010050510","volume":"22","author":"ACK Chung","year":"2011","unstructured":"Chung ACK, Lan HY (2011) Chemokines in renal injury. J Am Soc Nephrol 22(5):802\u2013809. https:\/\/doi.org\/10.1681\/ASN.2010050510","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"4226_CR13","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/s41573-021-00195-4","volume":"20","author":"P Cohen","year":"2021","unstructured":"Cohen P, Cross D, J\u00e4nne PA (2021) Kinase drug discovery 20 years after Imatinib: progress and future directions. Nat Rev Drug Discov 20(7):551\u2013569. https:\/\/doi.org\/10.1038\/s41573-021-00195-4","journal-title":"Nat Rev Drug Discov"},{"key":"4226_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcdb.2020.06.014","author":"GD Cuny","year":"2021","unstructured":"Cuny GD, Degterev A, Elsevier Ltd (2021) RIPK protein kinase family: atypical lives of typical kinases. Semin Cell Dev Biol. https:\/\/doi.org\/10.1016\/j.semcdb.2020.06.014","journal-title":"Semin Cell Dev Biol"},{"issue":"1","key":"4226_CR15","doi-asserted-by":"publisher","first-page":"245","DOI":"10.4049\/jimmunol.137.1.245","volume":"137","author":"ML Dustin","year":"1986","unstructured":"Dustin ML, Rothlein R, Bhan AK, Dinarello CA, Springer TA (1986) Induction by IL 1 and Interferon-Gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J Immunol 137(1):245\u2013254. https:\/\/doi.org\/10.4049\/jimmunol.137.1.245","journal-title":"J Immunol"},{"issue":"1","key":"4226_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12859-016-1433-7","volume":"18","author":"S Eid","year":"2017","unstructured":"Eid S, Turk S, Volkamer A, Rippmann F, Fulle S (2017) Kinmap: a web-based tool for interactive navigation through human kinome data. BMC Bioinform 18(1):1\u20136. https:\/\/doi.org\/10.1186\/s12859-016-1433-7","journal-title":"BMC Bioinform"},{"issue":"5","key":"4226_CR17","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/cyto.b.21168","volume":"86","author":"Z Erdei","year":"2014","unstructured":"Erdei Z, Lorincz R, Szeb\u00e9nyi K, P\u00e9ntek A, Varga N, Lik\u00f3 I, V\u00e1rady G et al (2014) Expression pattern of the human ABC transporters in pluripotent embryonic stem cells and in their derivatives. Cytometry B Clin Cytometry 86(5):299\u2013310. https:\/\/doi.org\/10.1002\/cyto.b.21168","journal-title":"Cytometry B Clin Cytometry"},{"issue":"2","key":"4226_CR18","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1681\/ASN.2018080853","volume":"30","author":"CC Estrada","year":"2019","unstructured":"Estrada CC, Maldonado A, Mallipattu SK (2019) Therapeutic inhibition of VEGF signaling and associated nephrotoxicities. J Am Soc Nephrol 30(2):187\u2013200. https:\/\/doi.org\/10.1681\/ASN.2018080853","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"4226_CR19","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1158\/1078-0432.CCR-11-0509","volume":"18","author":"KT Flaherty","year":"2012","unstructured":"Flaherty KT, LoRusso PM, DeMichele A, Abramson VG, Courtney R, Randolph SS, Naveed Shaik M, Wilner KD, O\u2019Dwyer PJ, Schwartz GK (2012) Phase I, dose-escalation trial of the oral cyclin-dependent kinase 4\/6 Inhibitor PD 0332991, administered using a 21-day schedule in patients with advanced cancer. Clin Cancer Res 18(2):568\u2013576. https:\/\/doi.org\/10.1158\/1078-0432.CCR-11-0509","journal-title":"Clin Cancer Res"},{"issue":"6","key":"4226_CR20","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1002\/hep.24314","volume":"53","author":"L Fredriksson","year":"2011","unstructured":"Fredriksson L, Herpers B, Benedetti G, Matadin Q, Puigvert JC, de Bont H, Dragovic S et al (2011) Diclofenac inhibits tumor necrosis factor-\u03b1-induced nuclear factor-\u03bab activation causing synergistic hepatocyte apoptosis. Hepatology 53(6):2027\u20132041. https:\/\/doi.org\/10.1002\/hep.24314","journal-title":"Hepatology"},{"issue":"8","key":"4226_CR21","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1101\/gr.240663.118","volume":"29","author":"L Garcia-Alonso","year":"2019","unstructured":"Garcia-Alonso L, Holland CH, Ibrahim MM, Turei D, Saez-Rodriguez J (2019) Benchmark and integration of resources for the estimation of human transcription factor activities. Genome Res 29(8):1363\u20131375. https:\/\/doi.org\/10.1101\/gr.240663.118","journal-title":"Genome Res"},{"issue":"5","key":"4226_CR22","doi-asserted-by":"publisher","first-page":"422","DOI":"10.2174\/092986708783503212","volume":"15","author":"S Giordano","year":"2008","unstructured":"Giordano S, Petrelli A (2008) From single- to multi-target drugs in cancer therapy: when aspecificity becomes an advantage. Curr Med Chem 15(5):422\u2013432","journal-title":"Curr Med Chem"},{"issue":"January","key":"4226_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2020.114915","volume":"391","author":"G Giustarini","year":"2020","unstructured":"Giustarini G, Huppelschoten S, Barra M, Oppelt A, Wagenaar L, Weaver RJ, Bol-Schoenmakers M et al (2020) The hepatotoxic fluoroquinolone trovafloxacin disturbs TNF- and LPS-induced P65 nuclear translocation in vivo and in vitro. Toxicol Appl Pharmacol 391(January):114915. https:\/\/doi.org\/10.1016\/j.taap.2020.114915","journal-title":"Toxicol Appl Pharmacol"},{"key":"4226_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23052815","author":"A Grela-Wojewoda","year":"2022","unstructured":"Grela-Wojewoda A, Pacholczak-Madej R, Adamczyk A, Korman M, P\u00fcsk\u00fcll\u00fco\u011flu M (2022) Cardiotoxicity induced by protein kinase inhibitors in patients with cancer. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23052815","journal-title":"Int J Mol Sci"},{"issue":"5","key":"4226_CR25","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1001\/jama.2010.39","volume":"303","author":"BR Hemmelgarn","year":"2010","unstructured":"Hemmelgarn BR, Manns BJ, Lloyd A, James MT, Klarenbach S, Quinn RR, Wiebe N, Tonelli M (2010) Relation between kidney function, proteinuria, and adverse outcomes. JAMA 303(5):423\u2013429. https:\/\/doi.org\/10.1001\/jama.2010.39","journal-title":"JAMA"},{"issue":"6","key":"4226_CR26","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1080\/17425255.2020.1755253","volume":"16","author":"KM Huang","year":"2020","unstructured":"Huang KM, Uddin ME, DiGiacomo D, Lustberg MB, Hu S, Sparreboom A (2020) Role of SLC transporters in toxicity induced by anticancer drugs. Expert Opin Drug Metab Toxicol 16(6):493\u2013506. https:\/\/doi.org\/10.1080\/17425255.2020.1755253","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"7","key":"4226_CR27","doi-asserted-by":"publisher","first-page":"927","DOI":"10.2215\/CJN.0000000000000395","volume":"19","author":"A Hulin","year":"2024","unstructured":"Hulin A, Gel\u00e9 T, Fenioux C, Kempf E, Sahali D, Tournigand C, Ollero M (2024) Pharmacology of tyrosine kinase inhibitors: implications for patients with kidney diseases. Clin J Am Soc Nephrol 19(7):927\u2013938. https:\/\/doi.org\/10.2215\/CJN.0000000000000395","journal-title":"Clin J Am Soc Nephrol"},{"issue":"0123456789","key":"4226_CR28","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1007\/s11886-024-02131-5","volume":"26","author":"E Hutchins","year":"2024","unstructured":"Hutchins E, Yang EH, Stein-Merlob AF (2024) Inflammation in chemotherapy-induced cardiotoxicity. Curr Cardiol Rep 26(0123456789):1329\u20131340. https:\/\/doi.org\/10.1007\/s11886-024-02131-5","journal-title":"Curr Cardiol Rep"},{"issue":"10","key":"4226_CR29","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1007\/s40262-020-00888-w","volume":"59","author":"AJ James","year":"2020","unstructured":"James AJ, Smith CC, Litzow M, Perl AE, Altman JK, Shepard D, Kadokura T et al (2020) Pharmacokinetic profile of Gilteritinib: a novel FLT-3 tyrosine kinase inhibitor. Clin Pharmacokinet 59(10):1273\u20131290. https:\/\/doi.org\/10.1007\/s40262-020-00888-w","journal-title":"Clin Pharmacokinet"},{"key":"4226_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16061137","author":"F Janku","year":"2024","unstructured":"Janku F, Choong GM, Opyrchal M, Dowlati A, Hierro C, Rodon J, Wicki A et al (2024) A phase I study of the oral dual-acting pan-PI3K\/MTOR inhibitor bimiralisib in patients with advanced solid tumors. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers16061137","journal-title":"Cancers (Basel)"},{"issue":"3","key":"4226_CR31","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1111\/j.1349-7006.2008.01064.x","volume":"100","author":"Y Kawai","year":"2009","unstructured":"Kawai Y, Kaidoh M, Yokoyama Y, Sano K, Ohhashi T (2009) Chemokine CCL2 facilitates ICAM-1-mediated interactions of cancer cells and lymphatic endothelial cells in sentinel lymph nodes. Cancer Sci 100(3):419\u2013428. https:\/\/doi.org\/10.1111\/j.1349-7006.2008.01064.x","journal-title":"Cancer Sci"},{"key":"4226_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-021-00284-z","author":"JA Kellum","year":"2021","unstructured":"Kellum JA, Romagnani P, Ashuntantang G, Ronco C, Zarbock A, Anders HJ (2021) Acute Kidney Injury. Nat Rev Dis Primers. https:\/\/doi.org\/10.1038\/s41572-021-00284-z","journal-title":"Nat Rev Dis Primers"},{"issue":"5","key":"4226_CR33","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1152\/ajprenal.00541.2007","volume":"296","author":"AB Kramer","year":"2009","unstructured":"Kramer AB, Van Timmeren MM, Schuurs TA, Vaidya VS, Bonventre JV, Van Goor H, Navis G (2009) Reduction of proteinuria in adriamycin-induced nephropathy is associated with reduction of renal kidney injury molecule (Kim-1) over time. Am J Physiol Renal Physiol 296(5):1136\u20131145. https:\/\/doi.org\/10.1152\/ajprenal.00541.2007","journal-title":"Am J Physiol Renal Physiol"},{"issue":"9","key":"4226_CR34","doi-asserted-by":"publisher","first-page":"6536","DOI":"10.4049\/jimmunol.181.9.6536","volume":"181","author":"JW Lee","year":"2008","unstructured":"Lee JW, Wang P, Kattah MG, Youssef S, Steinman L, DeFea K, Straus DS (2008) Differential regulation of chemokines by IL-17 in colonic epithelial cells. J Immunol 181(9):6536\u20136545. https:\/\/doi.org\/10.4049\/jimmunol.181.9.6536","journal-title":"J Immunol"},{"issue":"11","key":"4226_CR35","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1111\/febs.16442","volume":"290","author":"PY Lee","year":"2023","unstructured":"Lee PY, Yeoh Y, Low TY (2023) A recent update on small-molecule kinase inhibitors for targeted cancer therapy and their therapeutic insights from mass spectrometry-based proteomic analysis. FEBS J 290(11):2845\u20132864. https:\/\/doi.org\/10.1111\/febs.16442","journal-title":"FEBS J"},{"issue":"12","key":"4226_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S (2014) Moderated estimation of fold change and dispersion for RNA-Seq data with DESeq2. Genome Biol 15(12):1\u201321. https:\/\/doi.org\/10.1186\/s13059-014-0550-8","journal-title":"Genome Biol"},{"issue":"5600","key":"4226_CR38","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1126\/science.1075762","volume":"298","author":"G Manning","year":"2002","unstructured":"Manning G, Whyte DB, Martinez R, Hunter T, Sudarsanam S (2002) The protein kinase complement of the human genome. Science 298(5600):1912\u20131934. https:\/\/doi.org\/10.1126\/science.1075762","journal-title":"Science"},{"key":"4226_CR39","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02198-16","author":"MD Mar Castro","year":"2017","unstructured":"Mar Castro MD, Gomez MA, Kip AE, Cossio A, Ortiz E, Navas A, Dorlo TPC, Saravia NG (2017) Pharmacokinetics of miltefosine in children and adults with cutaneous leishmaniasis. Antimicrob Agents Chemotherapy. https:\/\/doi.org\/10.1128\/AAC.02198-16","journal-title":"Antimicrob Agents Chemotherapy"},{"issue":"9","key":"4226_CR40","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1007\/s40265-019-01142-9","volume":"79","author":"A Markham","year":"2019","unstructured":"Markham A (2019) Erdafitinib: first global approval. Drugs 79(9):1017\u20131021. https:\/\/doi.org\/10.1007\/s40265-019-01142-9","journal-title":"Drugs"},{"issue":"1","key":"4226_CR41","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1080\/0886022X.2021.1874985","volume":"43","author":"C Mark\u00f3th","year":"2021","unstructured":"Mark\u00f3th C, File I, Sz\u00e1sz R, Bidiga L, Balla J, M\u00e1tyus J (2021) Ibrutinib-induced acute kidney injury via interstitial nephritis. Ren Fail 43(1):335\u2013339. https:\/\/doi.org\/10.1080\/0886022X.2021.1874985","journal-title":"Ren Fail"},{"issue":"11","key":"4226_CR42","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.3390\/toxins2112490","volume":"2","author":"RP Miller","year":"2010","unstructured":"Miller RP, Tadagavadi RK, Ramesh G, Reeves WB (2010) Mechanisms of cisplatin nephrotoxicity. Toxins 2(11):2490\u20132518. https:\/\/doi.org\/10.3390\/toxins2112490","journal-title":"Toxins"},{"issue":"6","key":"4226_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2021.118992","volume":"1868","author":"SM Post","year":"2021","unstructured":"Post SM, Andreeff M, DiNardo C, Khoury JD, Ruvolo PP (2021) Tam kinases as regulators of cell death. Biochimica Et Biophysica Acta - Mol Cell Res 1868(6):118992. https:\/\/doi.org\/10.1016\/j.bbamcr.2021.118992","journal-title":"Biochimica Et Biophysica Acta - Mol Cell Res"},{"key":"4226_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106552","volume":"187","author":"R Roskoski","year":"2023","unstructured":"Roskoski R (2023) Properties of FDA-approved small molecule protein kinase inhibitors: a 2023 update. Pharmacol Res 187:106552. https:\/\/doi.org\/10.1016\/j.phrs.2022.106552. ((November 2022))","journal-title":"Pharmacol Res"},{"issue":"1","key":"4226_CR45","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1158\/1078-0432.CCR-14-0947","volume":"21","author":"D Sarker","year":"2015","unstructured":"Sarker D, Ang JE, Baird R, Kristeleit R, Shah K, Moreno V, Clarke PA et al (2015) First-in-human phase I study of Pictilisib (GDC-0941), a potent pan-class I phosphatidylinositol-3-kinase (PI3K) inhibitor, in patients with advanced solid tumors. Clin Cancer Res 21(1):77\u201386. https:\/\/doi.org\/10.1158\/1078-0432.CCR-14-0947","journal-title":"Clin Cancer Res"},{"issue":"4","key":"4226_CR46","doi-asserted-by":"publisher","first-page":"183","DOI":"10.12793\/tcp.2017.25.4.183","volume":"25","author":"H-B Seo","year":"2017","unstructured":"Seo H-B, Cho S, Yoon Y-R, Yim D-S (2017) Development and validation of analytical method for the determination of Radotinib in human plasma using liquid chromatography-tandem mass spectrometry. Transl Clin Pharmacol 25(4):183\u2013189","journal-title":"Transl Clin Pharmacol"},{"key":"4226_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01469-6","author":"S Shyam Sunder","year":"2023","unstructured":"Shyam Sunder S, Sharma UC, Pokharel S (2023) Adverse effects of tyrosine kinase inhibitors in cancer therapy: pathophysiology, mechanisms and clinical management. Signal Transduct Target Therapy. https:\/\/doi.org\/10.1038\/s41392-023-01469-6","journal-title":"Signal Transduct Target Therapy"},{"issue":"May","key":"4226_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2023.117487","volume":"548","author":"V Singh","year":"2023","unstructured":"Singh V, Kaur R, Kumari P, Pasricha C, Singh R (2023) ICAM-1 and VCAM-1: gatekeepers in various inflammatory and cardiovascular disorders. Clin Chim Acta 548(May):117487. https:\/\/doi.org\/10.1016\/j.cca.2023.117487","journal-title":"Clin Chim Acta"},{"key":"4226_CR49","doi-asserted-by":"publisher","unstructured":"Szklarczyk, D, R Kirsch, M Koutrouli, K Nastou, F Mehryary, R Hachilif, AL Gable, et al (2023) The STRING Database in 2023: Protein-Protein Association Networks and Functional Enrichment Analyses for Any Sequenced Genome of Interest. Nucleic Acids Res 51(1 D):D638\u2013D646. https:\/\/doi.org\/10.1093\/nar\/gkac1000","DOI":"10.1093\/nar\/gkac1000"},{"issue":"6","key":"4226_CR50","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1681\/ASN.2009070741","volume":"21","author":"JE Turner","year":"2010","unstructured":"Turner JE, Paust HJ, Steinmetz OM, Peters A, Riedel JH, Erhardt A, Wegscheid C et al (2010) Ccr6 recruits regulatory T cells and Th17 cells to the kidney in glomerulonephritis. J Am Soc Nephrol 21(6):974\u2013985. https:\/\/doi.org\/10.1681\/ASN.2009070741","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"4226_CR36","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/s41577-022-00792-3","volume":"23","author":"G van Loo","year":"2023","unstructured":"van Loo G, Bertrand MJM (2023) Death by TNF: a road to inflammation. Nat Rev Immunol 23(5):289\u2013303. https:\/\/doi.org\/10.1038\/s41577-022-00792-3","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"4226_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers15061766","volume":"15","author":"M Vigan\u00f2","year":"2023","unstructured":"Vigan\u00f2 M, La Milia M, Grassini MV, Pugliese N, De Giorgio M, Fagiuoli S (2023) Hepatotoxicity of small molecule protein kinase inhibitors for cancer. Cancers 15(6):1\u201334. https:\/\/doi.org\/10.3390\/cancers15061766","journal-title":"Cancers"},{"key":"4226_CR52","doi-asserted-by":"publisher","DOI":"10.1111\/liv.15822","author":"M Vlasveld","year":"2024","unstructured":"Vlasveld M, Callegaro G, Fisher C, Eakins J, Walker P, Lok S, Van Oost S et al (2024) The integrated stress response- related expression of CHOP due to mitochondrial toxicity is a warning sign for DILI liability. Liver Int. https:\/\/doi.org\/10.1111\/liv.15822","journal-title":"Liver Int"},{"issue":"25","key":"4226_CR53","first-page":"1","volume":"26","author":"V Volarevic","year":"2019","unstructured":"Volarevic V, Djokovic B, Gazdic Jankovic M, Harrell CR, Fellabaum C, Djonov V, Arsenijevic N (2019) Molecular mechanisms of Cisplatin-induced nephrotoxicity: a balance on the knife edge between renoprotection and tumor toxicity. J Biomed Sci 26(25):1\u201314","journal-title":"J Biomed Sci"},{"issue":"8","key":"4226_CR54","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.1007\/s11255-024-03989-8","volume":"56","author":"H Wang","year":"2024","unstructured":"Wang H, Gao L, Zhao C, Fang F, Liu J, Wang Z, Zhong Y, Wang X (2024) The role of PI3K\/Akt signaling pathway in chronic kidney disease. Int Urol Nephrol 56(8):2623\u20132633. https:\/\/doi.org\/10.1007\/s11255-024-03989-8","journal-title":"Int Urol Nephrol"},{"issue":"1","key":"4226_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-023-02838-2","volume":"21","author":"H Wang","year":"2023","unstructured":"Wang H, Wang Y, Li J, He Z, Boswell SA, Chung M, You F, Han S (2023) Three tyrosine kinase inhibitors cause cardiotoxicity by inducing endoplasmic reticulum stress and inflammation in cardiomyocytes. BMC Med 21(1):1\u201321. https:\/\/doi.org\/10.1186\/s12916-023-02838-2","journal-title":"BMC Med"},{"issue":"22","key":"4226_CR56","doi-asserted-by":"publisher","first-page":"6631","DOI":"10.1158\/0008-5472.CAN-15-3034","volume":"76","author":"L Wang","year":"2016","unstructured":"Wang L, Chen Q, Qi H, Wang C, Wang C, Zhang J, Dong L (2016) Doxorubicin-induced systemic inflammation is driven by upregulation of toll-like receptor TLR4 and endotoxin leakage. Cancer Res 76(22):6631\u20136642. https:\/\/doi.org\/10.1158\/0008-5472.CAN-15-3034","journal-title":"Cancer Res"},{"issue":"May","key":"4226_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fcell.2020.00365","volume":"8","author":"JD Webster","year":"2020","unstructured":"Webster JD, Vucic D (2020) The balance of TNF mediated pathways regulates inflammatory cell death signaling in healthy and diseased tissues. Front Cell Develop Biol 8(May):1\u201314. https:\/\/doi.org\/10.3389\/fcell.2020.00365","journal-title":"Front Cell Develop Biol"},{"key":"4226_CR58","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.00365","author":"Webster JD, Vucic D","year":"2020","unstructured":"Webster JD, Vucic D (2020b) The balance of TNF mediated pathways regulates inflammatory cell death signaling in healthy and diseased tissues. Front Cell Develop Biol. https:\/\/doi.org\/10.3389\/fcell.2020.00365","journal-title":"Front Cell Develop Biol"},{"issue":"8","key":"4226_CR59","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1158\/1078-0432.CCR-19-2808","volume":"26","author":"PY Wen","year":"2020","unstructured":"Wen PY, Cloughesy TF, Olivero AG, Morrissey KM, Wilson TR, Lu X, Mueller LU et al (2020) First-in-human phase i study to evaluate the brain-penetrant PI3K\/MTOR inhibitor GDC-0084 in patients with progressive or recurrent high-grade glioma. Clin Cancer Res 26(8):1820\u20131828. https:\/\/doi.org\/10.1158\/1078-0432.CCR-19-2808","journal-title":"Clin Cancer Res"},{"issue":"4","key":"4226_CR60","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1634\/theoncologist.2016-0257","volume":"22","author":"J Wheler","year":"2017","unstructured":"Wheler J, Mutch D, Lager J, Castell C, Liu Li, Jiang J, Traynor AM (2017) Phase I dose-escalation study of Pilaralisib (SAR245408, XL147) in combination with paclitaxel and carboplatin in patients with solid tumors. Oncologist 22(4):377-e37. https:\/\/doi.org\/10.1634\/theoncologist.2016-0257","journal-title":"Oncologist"},{"issue":"5","key":"4226_CR61","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1007\/s40495-018-0147-0","volume":"4","author":"BL Woolbright","year":"2018","unstructured":"Woolbright BL, Jaeschke H (2018) Mechanisms of inflammatory liver injury and drug-induced hepatotoxicity. Curr Pharmacol Rep 4(5):346\u201357. https:\/\/doi.org\/10.1007\/s40495-018-0147-0","journal-title":"Curr Pharmacol Rep"},{"issue":"8","key":"4226_CR62","doi-asserted-by":"publisher","first-page":"843","DOI":"10.3851\/IMP2958.Liver-to-plasma","volume":"20","author":"DH Wright","year":"2015","unstructured":"Wright DH, Caro L, Cerra M, Panorchan P, Lihong Du, Anderson M, Potthoff A et al (2015) Liver-to-Plasma Vaniprevir (MK-7009) Concentration Ratios in HCV-Infected Patients. Antivir Ther 20(8):843\u201348. https:\/\/doi.org\/10.3851\/IMP2958.Liver-to-plasma","journal-title":"Antivir Ther"},{"key":"4226_CR63","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1023660","author":"Y Xiong","year":"2022","unstructured":"Xiong Y, Wang Q, Liu Y, Wei J, Chen X (2022) Renal adverse reactions of tyrosine kinase inhibitors in the treatment of tumours: a bayesian network meta-analysis. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2022.1023660","journal-title":"Front Pharmacol"},{"key":"4226_CR64","doi-asserted-by":"publisher","unstructured":"Yan K, Verbeek FJ (2012).Segmentation for high-throughput image analysis: watershed masked clustering. In: Lecture Notes in Computer Sciences, 7610 LNCS:25\u201341. Springer, Berlin, Heidelberg. https:\/\/doi.org\/10.1007\/978-3-642-34032-1_4","DOI":"10.1007\/978-3-642-34032-1_4"},{"issue":"1","key":"4226_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40779-015-0039-0","volume":"2","author":"Y Yang","year":"2015","unstructured":"Yang Y, Jiang G, Zhang P, Fan J (2015) Programmed cell death and its role in inflammation. Mil Med Res 2(1):1\u201312. https:\/\/doi.org\/10.1186\/s40779-015-0039-0","journal-title":"Mil Med Res"},{"issue":"1","key":"4226_CR66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-018-06500-x","volume":"9","author":"C Ye","year":"2018","unstructured":"Ye C, Ho DJ, Neri M, Yang C, Kulkarni T, Randhawa R, Henault M et al (2018) DRUG-Seq for miniaturized high-throughput transcriptome profiling in drug discovery. Nat Commun 9(1):1\u20139. https:\/\/doi.org\/10.1038\/s41467-018-06500-x","journal-title":"Nat Commun"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-025-04226-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00204-025-04226-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-025-04226-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T06:31:51Z","timestamp":1770618711000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00204-025-04226-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,5]]},"references-count":66,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["4226"],"URL":"https:\/\/doi.org\/10.1007\/s00204-025-04226-6","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,5]]},"assertion":[{"value":"15 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}